Literature DB >> 12151147

Frequency of congenital varicella syndrome in a prospective cohort of 347 pregnant women.

James H Harger1, Joseph M Ernest, Gary R Thurnau, Atef Moawad, Elizabeth Thom, Mark B Landon, Richard Paul, Menachem Miodovnik, Mitchell Dombrowski, Baha Sibai, Peter Van Dorsten, Donald McNellis.   

Abstract

OBJECTIVE: To estimate the rate of congenital varicella zoster virus syndrome in neonates born to women developing varicella zoster virus infections during pregnancy.
METHODS: Pregnant women with clinical varicella zoster virus infection were enrolled at ten perinatal centers. Maternal and fetal immunoglobulin (Ig) G and IgM by fluorescent antibody confirmed 74.3% of cases. Specialists examined neonates at 0-6 months, 7-18 months, and 19-30 months after delivery to detect abnormalities of their eyes, hearing, and physical and developmental features. A hierarchical set of criteria was used to define congenital varicella syndrome. A jury of four investigators assigned the classification of all findings.
RESULTS: In 362 women enrolled from 1993 to 1996, 15 had herpes zoster, and 347 had primary varicella zoster virus infection. Varicella zoster virus affected 140 women (38.7%) in the first trimester, 122 (33.7%) in the second trimester, and 100 (27.6%) in the third trimester. Five twin pairs were included. Only one case (0.4%) of definite congenital varicella syndrome was found, a 3360-g female infant having a left retinal macular lesion with typical skin scars after maternal varicella at 24 weeks. The maternal blood sample at birth was negative for IgG antibodies to toxoplasmosis and cytomegalovirus. Two cases involved fetal death at 20 weeks and fetal hydrops at 17 weeks after maternal varicella at 11 and 5 weeks, respectively. We found no cases of limb hypoplasia, microcephalus, or cataract.
CONCLUSION: The frequency of congenital varicella syndrome is very low (0.4%) in a prospectively studied cohort. Eye examinations of exposed infants had a low yield.

Entities:  

Mesh:

Year:  2002        PMID: 12151147     DOI: 10.1016/s0029-7844(02)02059-8

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  12 in total

1.  Risk of varicella infection during late pregnancy.

Authors:  Gideon Koren
Journal:  Can Fam Physician       Date:  2003-11       Impact factor: 3.275

Review 2.  Viral pulmonary infection in pregnancy - Including COVID-19, SARS, influenza A, and varicella.

Authors:  Ashwini Maudhoo; Asma Khalil
Journal:  Best Pract Res Clin Obstet Gynaecol       Date:  2022-07-09       Impact factor: 4.268

Review 3.  Microbiology laboratory and the management of mother-child varicella-zoster virus infection.

Authors:  Massimo De Paschale; Pierangelo Clerici
Journal:  World J Virol       Date:  2016-08-12

4.  Shingles in Pregnancy: An Elusive Case of Left Upper Quadrant Abdominal Pain.

Authors:  Jennifer Wh Wong; Jennifer My Chin; Ryan J Schlueter
Journal:  Hawaii J Med Public Health       Date:  2018-08

Review 5.  The role of ultrasound in the diagnosis of fetal genetic syndromes.

Authors:  Shayna N Conner; Ryan E Longman; Alison G Cahill
Journal:  Best Pract Res Clin Obstet Gynaecol       Date:  2014-01-28       Impact factor: 5.237

6.  Validity of self-reported varicella disease history in pregnant women attending prenatal clinics.

Authors:  Barbara Watson; Rachel Civen; Meredith Reynolds; Karl Heath; Dana Perella; Tina Carbajal; Laurene Mascola; Aisha Jumaan; Laura Zimmerman; Abike James; Carlene Quashi; Scott Schmid
Journal:  Public Health Rep       Date:  2007 Jul-Aug       Impact factor: 2.792

7.  Cost-effectiveness analysis of universal varicella vaccination in Turkey using a dynamic transmission model.

Authors:  Lara J Wolfson; Vincent J Daniels; Matthew Pillsbury; Zafer Kurugöl; Cuneyt Yardimci; Jeffrey Kyle; Ener Cagri Dinleyici
Journal:  PLoS One       Date:  2019-08-13       Impact factor: 3.240

8.  Varicella zoster immune globulin (VARIZIG) administration up to 10 days after varicella exposure in pregnant women, immunocompromised participants, and infants: Varicella outcomes and safety results from a large, open-label, expanded-access program.

Authors:  Myron J Levin; Jennifer M Duchon; Geeta K Swamy; Anne A Gershon
Journal:  PLoS One       Date:  2019-07-03       Impact factor: 3.240

9.  Genitourinary anomaly in congenital varicella syndrome: case report and review.

Authors:  Hisayo Fujita; Akira Yoshii; Jun Maeda; Kenjiro Kosaki; Seiichiro Shishido; Hideo Nakai; Midori Awazu
Journal:  Pediatr Nephrol       Date:  2004-03-10       Impact factor: 3.651

Review 10.  Lights and Shadows of TORCH Infection Proteomics.

Authors:  Janaina Macedo-da-Silva; Claudio Romero Farias Marinho; Giuseppe Palmisano; Livia Rosa-Fernandes
Journal:  Genes (Basel)       Date:  2020-08-05       Impact factor: 4.096

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.